Globus Medical Launches ANTHEM™ Elbow Fracture System: A Comprehensive Plating Portfolio for Complex Elbow Trauma
Globus Medical (NYSE: GMED) launched the ANTHEM™ Elbow Fracture System on October 14, 2025, a comprehensive plating portfolio for a wide spectrum of elbow fractures.
The system includes 14 plate families, 2.7mm and 3.5mm screw options, anatomy-specific reduction instruments, and polyaxial locking holes that permit fixed-angle or 40º cone angulation for flexible fixation. Devices target distal humerus, proximal ulna, proximal radius, and coronoid fractures and are designed to simplify surgical workflow for complex patterns.
Globus Medical (NYSE: GMED) ha lanciato l'ANTHEM™ Elbow Fracture System il 14 ottobre 2025, una ricca gamma di placche per un ampio spettro di fratture del gomito.
Il sistema include 14 famiglie di placche, opzioni di viti da 2,7 mm e 3,5 mm, strumenti di riduzione specifici per l'anatomia e fori di bloccaggio poliassiali che permettono una fissazione a angolo fisso o una angolazione a cono di 40º per una fissazione flessibile. I dispositivi mirano a fratture dell'omero distale, ulna prossimale, radio prossimale e coronoide e sono progettati per semplificare il flusso di lavoro chirurgico per schemi complessi.
Globus Medical (NYSE: GMED) lanzó el ANTHEM™ Elbow Fracture System el 14 de octubre de 2025, una cartera de placas completa para un amplio espectro de fracturas del codo.
El sistema incluye 14 familias de placas, opciones de tornillos de 2.7 mm y 3.5 mm, instrumentos de reducción específicos de la anatomía y orificios de bloqueo poli axial que permiten una fijación con ángulo fijo o una angulación de cono de 40º para una fijación flexible. Los dispositivos están dirigidos a fracturas del húmero distal, ulna proximal, radio proximal y coronoide y están diseñados para simplificar el flujo quirúrgico en patrones complejos.
Globus Medical (NYSE: GMED)는 2025년 10월 14일 ANTHEM™ Elbow Fracture System를 출시했으며, 팔꿈치 골절의 광범위한 스펙트럼에 대응하는 포괄적인 플레이트 포트폴리오를 제공합니다.
시스템은 14개의 플레이트 패밀리, 2.7mm 및 3.5mm 나사 옵션, 해부학에 특정한 부합 감소 도구, 고정 각도 또는 40º 콘 각도를 허용하는 폴리아크시얼 락킹 구멍을 포함하여 설계되어 복합 패턴의 수술 워크플로우를 단순화합니다. 기기는 원위상완골, 상완골 proximal, 요골 proximal 및 코로노이드 골절에 표적을 두고 있으며, 복잡한 패턴의 수술 워크플로우를 단순화하도록 고안되었습니다.
Globus Medical (NYSE: GMED) a lancé le ANTHEM™ Elbow Fracture System le 14 octobre 2025, une gamme complète de plaques pour un large éventail de fractures du coude.
Le système comprend 14 familles de plaques, des options de vis de 2,7 mm et 3,5 mm, des instruments de réduction spécifiques à l’anatomie et des orifices de verrouillage polyaxiaux qui permettent une fixation angulaire fixe ou une angulation en cône de 40° pour une fixation flexible. Les dispositifs visent les fractures de l’humérus distal, de l’ulna proximal, du radius proximal et de la coronoïde et sont conçus pour simplifier le flux chirurgical pour des motifs complexes.
Globus Medical (NYSE: GMED) hat am 14. Oktober 2025 das ANTHEM™ Elbow Fracture System eingeführt, ein umfassendes Plattenportfolio für ein breites Spektrum von Ellenbogenfrakturen.
Das System umfasst 14 Plattenfamilien, Schraubenoptionen von 2,7 mm und 3,5 mm, anatomie-spezifische Reduktionswerkzeuge und polyaxiale Verriegelungslöcher, die eine Fixed-Angle- oder eine 40°-Kegel-Winkelung für flexible Fixierung ermöglichen. Die Geräte zielen auf Frakturen des distalen Humerus, des proximalen Ulna, des proximalen Radius und der Koronoidfrakturen ab und sind darauf ausgelegt, den chirurgischen Arbeitsablauf bei komplexen Mustern zu vereinfachen.
Globus Medical (NYSE: GMED) أطلقت في 14 أكتوبر 2025 ANTHEM™ Elbow Fracture System، وهو مجموعة كاملة من لوحات التثبيت لسلسلة واسعة من كسور الكوع.
يشمل النظام 14 عائلة لوحات، خيارات براغي 2.7 مم و3.5 مم، وأدوات تقليل تتوافق مع التشريح، وفوهات قفل بولي-زايا تسمح بالتثبيت بزوايا ثابتة أو بزوايا مخروطية 40° لتثبيت مرن. تستهدف الأجهزة كسور عظمي الكوع في المرفق السفلي للعضد، والكوع القريب، والزند القريب، والقرنود، ومصممة لتبسيط سير العمل الجراحي لأنماطة معقدة.
Globus Medical (NYSE: GMED) 于 2025年10月14日 推出 ANTHEM™ Elbow Fracture System，一个覆盖广泛的肘部骨折的综合钉板系列。
该系统包括 14 种板型家族、2.7mm 与 3.5mm 螺钉选项、解剖学特异的复位工具，以及允许固定角度或 40° 锥形角 的多轴锁定孔，提供灵活固定。器械针对远端肱骨、近端尺骨、近端桡骨和冠状突骨折，旨在简化复杂模式的手术工作流程。
- None.
- None.
Insights
Globus Medical launched a broad, anatomy-specific elbow plating system aimed at simplifying fixation for complex elbow fractures.
Globus Medical introduced the ANTHEM™ Elbow Fracture System on
The disclosed practical benefits include calibrated drill guides and polyaxial locking technology that permit fixed-angle or variable-angle fixation while helping avoid intra-articular penetration, supported by an initial surgeon endorsement describing good fit and minimal triceps disruption. Key dependencies and risks are clinical adoption, training on the multi-family system, and real-world performance across diverse fracture patterns; these depend on surgeon acceptance and hospital procurement decisions described in the release. Monitor commercial rollout metrics and surgeon feedback in the months after
AUDUBON, Pa., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, has announced the launch of the ANTHEM™ Elbow Fracture System, a fully comprehensive plating portfolio designed to address a wide spectrum of elbow fractures.
The ANTHEM™ Elbow Fracture System is designed to offer surgeons anatomically contoured plates to treat a variety of fractures, regardless of severity or complexity, with a simplified workflow.
Engineered to simplify surgical workflows while offering versatility, the ANTHEM™ Elbow Fracture System provides anatomically contoured plates tailored for distal humerus, proximal ulna, proximal radius, and coronoid fractures. With 14 plate families, 2.7mm and 3.5mm screw options, and anatomy-specific reduction instruments, the system empowers surgeons to treat even the most complex fracture patterns .
All plates in the portfolio feature polyaxial locking technology, to enable either fixed-angle trajectories or screw placement within a 40º cone of angulation, offering flexibility in accommodating fixation strategies.
“In the first clinical use of the ANTHEM™ Elbow Fracture System, I found the design to be both practical and reliable. The anatomically contoured plates fit well to the bone and supported fixation with minimal disruption of the triceps,” says Dr. Gary Updegrove, Penn State Health, Hershey, Pa. "The polyaxial locking holes, combined with calibrated drill guides, helped support precise screw placement and allowed me to achieve strong fixation while easily avoiding intra-articular penetration. As someone who specializes in complex elbow fracture surgery and upper extremity trauma care, I especially appreciated the flexibility of the system — with multiple plate families and screw options available, I could tailor the construct to match the complexity of each fracture pattern in this case. This is exactly the kind of thoughtful design that makes a difference in elbow trauma surgery.”
“The launch of the ANTHEM™ Elbow Fracture System marks another milestone in our commitment to advancing trauma care,” says John Mulchay, President of Orthopedics and Chief Commercial Officer at Globus Medical. “By delivering a comprehensive and intuitive solution for elbow fractures, we’re equipping surgeons with the tools they need to provide outstanding care and streamline procedures.”
The ANTHEM™ Elbow Fracture System is the latest addition to Globus Medical’s expanding Trauma Portfolio, reinforcing the company’s dedication to innovation and excellence in musculoskeletal care.
Learn more about the ANTHEM™ Elbow Fracture System: https://www.globusmedical.com/musculoskeletal-solutions/trauma/
About Globus Medical, Inc.
Globus Medical, Inc. is a leading global musculoskeletal company dedicated to solving unmet clinical needs and changing lives. We innovate with inspired urgency, provide world-class education and clinical support, and advance care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling technologies. Additional information can be accessed at www.globusmedical.com.
Safe Harbor Statements
All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, the risks and costs associated with the health epidemics, pandemics and similar outbreaks, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to comply with laws and regulations that are or may become applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, you should refer to the disclosure contained in our most recent annual report on Form 10-K filed with the U.S. Securities and Exchange Commission, including the sections labeled “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements,” and in our Forms 10-Q, Forms 8-K and other filings with the U.S. Securities and Exchange Commission. These documents are available at www.sec.gov. Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release. We undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof.
Investor contact:
Brian Kearns
610-930-1800
investors@globusmedical.com
Media contact:
Moran Chavez
media@globusmedical.com
FAQ
What is the ANTHEM Elbow Fracture System launched by Globus Medical (GMED) on October 14, 2025?
Which elbow fracture types does the ANTHEM System (GMED) address?
What fixation flexibility does Globus Medical's ANTHEM System (GMED) offer surgeons?
Does the ANTHEM Elbow Fracture System (GMED) include surgical instruments?
What screw sizes are available in the ANTHEM Elbow Fracture System from Globus Medical (GMED)?
How does Globus Medical (GMED) say the ANTHEM System impacts surgical workflow?
